Semaglutide and Glaucoma: Navigating Your Eye Health Journey

Introduction

For many individuals, the journey toward better health often involves managing complex conditions simultaneously. When considering advanced weight loss and blood sugar management solutions like semaglutide, questions naturally arise about their potential interactions with existing health concerns. One such concern that frequently surfaces involves eye health, particularly for those living with glaucoma – a condition often referred to as the “silent thief of sight.” The intersection of metabolic health and ocular well-being is a fascinating and evolving area of medical research, presenting both promising new avenues and important considerations for patient care.

Our goal at TrimRx has always been to empower individuals to embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions. We understand that health decisions are deeply personal and require a foundation of comprehensive, trustworthy information. This blog post is dedicated to shedding light on the intricate relationship between semaglutide—a powerful medication in the GLP-1 receptor agonist class—and glaucoma. We will delve into what semaglutide is, how glaucoma impacts vision, and crucially, explore the current understanding of how these two elements interact.

Throughout this discussion, we will examine the latest research, including ongoing clinical trials that are actively investigating the potential effects of semaglutide on glaucoma. We aim to provide clarity on both the potential benefits being explored and the considerations that individuals with glaucoma, or those at risk, should discuss with their healthcare providers. Our commitment is to offer compassionate care that respects every individual’s unique journey by combining advanced medical science with modern technology. By the end of this article, you will have a more informed perspective, helping you engage in a more productive dialogue with your medical team about whether semaglutide aligns with your overall health goals, especially concerning your eye health. Together, we’ll navigate this complex topic to ensure you have the most up-to-date and relevant insights.

Understanding Semaglutide: A Modern Approach to Health Management

Semaglutide is a medication that has garnered significant attention for its remarkable efficacy in two key areas: managing type 2 diabetes and supporting weight loss. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it represents a modern frontier in metabolic health, offering a mechanism of action that goes beyond traditional treatments. At TrimRx, we believe in supporting individuals with solutions grounded in science and delivered with empathy. Our personalized programs often incorporate medications like semaglutide, provided through FDA-registered and inspected pharmacies, as part of a comprehensive strategy for sustainable well-being.

What is Semaglutide and How Does It Work?

Semaglutide belongs to a class of medications known as GLP-1 receptor agonists. GLP-1 is a natural hormone produced in the gut that plays a crucial role in regulating blood sugar levels and appetite. When you eat, GLP-1 is released, stimulating the pancreas to produce more insulin, which helps move glucose from the bloodstream into cells for energy. Concurrently, GLP-1 inhibits the release of glucagon, a hormone that raises blood sugar, and slows gastric emptying, which helps you feel fuller for longer.

By mimicking the action of natural GLP-1, semaglutide achieves several beneficial effects:

• Blood Sugar Regulation: It significantly lowers blood glucose levels in people with type 2 diabetes, often leading to improved A1C levels.
• Weight Management: By slowing digestion and promoting a feeling of fullness, it can reduce calorie intake and contribute to substantial weight loss in individuals with obesity or who are overweight with related health conditions.

This dual action makes semaglutide a powerful tool for those navigating the challenges of metabolic health. At TrimRx, we emphasize that these medications are not a standalone solution but are most effective when integrated into a holistic lifestyle approach that includes dietary adjustments and regular physical activity.

Approved Uses and Personalized Programs

Semaglutide is available in various forms and under different brand names, each with specific FDA approvals:

• For Type 2 Diabetes: Ozempic® (injectable) and Rybelsus® (oral) are approved to help control blood sugar in adults with type 2 diabetes. Ozempic® is also approved to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
• For Weight Management: Wegovy® (injectable) is specifically approved for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition.

TrimRx offers a range of these clinically proven prescription weight loss medications, including Compounded Semaglutide, Oral Semaglutide, Ozempic®, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, and Wegovy®. Our approach is deeply personalized. We understand that each individual’s body and health profile are unique, which is why we require a comprehensive assessment to ensure the safest and most effective treatment plan. To determine if you qualify for one of our personalized prescription weight loss programs, we encourage you to take our free assessment quiz. This quiz helps our medical team understand your health history and goals, paving the way for a tailored approach that prioritizes your safety and long-term success.

Our service includes thorough doctor consultations, necessary lab work, the medication itself (shipped from FDA-registered and inspected pharmacies), unlimited support from our care team, and transparent shipping, all without hidden fees. We partner with FDA-registered and inspected pharmacies to ensure the highest standards for the medications provided, ensuring that our approach remains consistent regardless of dosage changes.

Glaucoma: An Overview of the Silent Thief of Sight

To truly understand the implications of taking semaglutide if you have glaucoma, it is essential to first grasp what glaucoma is and how it affects vision. Glaucoma is not a single eye condition but a group of diseases that damage the optic nerve, the crucial cable that transmits visual information from the eye to the brain. This damage often leads to irreversible vision loss and, if left untreated, can result in blindness. It is considered a leading cause of irreversible blindness worldwide, affecting millions of people.

What is Glaucoma and How Does It Damage Vision?

The optic nerve is comprised of a bundle of nerve fibers, known as retinal ganglion cells and their axons, which are vital for clear and comprehensive vision. In most forms of glaucoma, this nerve damage is associated with elevated intraocular pressure (IOP), which is the pressure inside the eye. While high IOP is a significant risk factor, it’s important to note that glaucoma can also develop in individuals with normal eye pressure, a condition known as normal-tension glaucoma.

The progression of glaucoma is typically slow and insidious. In its early stages, it often affects peripheral vision, meaning individuals may not notice any symptoms until substantial and irreversible damage has occurred. This “silent” nature is why regular comprehensive eye exams, especially for those at higher risk, are so critical. As the disease advances, the field of vision narrows further, eventually leading to tunnel vision and, in severe cases, complete vision loss. Currently, there is no cure for glaucoma, and vision lost to the condition cannot be restored.

Primary Risk Factors and Current Treatment Strategies

Several factors increase an individual’s risk of developing glaucoma:

• Age: The risk significantly increases with age, particularly after 60.
• Family History: A genetic predisposition plays a strong role; having a family member with glaucoma increases your own risk.
• Ethnicity: Certain ethnic groups, such as African Americans, Hispanic Americans, and Asian Americans, have a higher prevalence of specific types of glaucoma.
• Medical Conditions: Diabetes, high blood pressure, heart disease, and sickle cell anemia can increase risk.
• Eye Conditions: Thin corneas, extreme nearsightedness or farsightedness, and previous eye injuries or surgeries.
• Corticosteroid Use: Prolonged use of corticosteroid medications, especially eye drops, can raise IOP.

Current treatment strategies for glaucoma primarily focus on lowering intraocular pressure to prevent further damage to the optic nerve. These treatments include:

• Eye Drops: Prescription eye drops are the most common initial treatment, working to either reduce fluid production in the eye or increase fluid outflow.
• Oral Medications: In some cases, oral medications may be prescribed to further lower IOP.
• Laser Treatment: Procedures like selective laser trabeculoplasty (SLT) or argon laser trabeculoplasty (ALT) can help increase fluid drainage from the eye.
• Surgery: When other treatments are insufficient, surgical procedures such as trabeculectomy or implanting drainage devices can create new pathways for fluid to exit the eye.

While these treatments are effective in preserving remaining vision by controlling IOP, they do not address the underlying neurodegeneration of the optic nerve directly. This limitation has spurred significant research into neuroprotective strategies, including the investigation of novel compounds that might shield the optic nerve from damage, independent of pressure reduction. This is where GLP-1 receptor agonists, like semaglutide, enter the conversation, offering a potential new avenue for exploration.

Navigating the Nuances: Semaglutide and Ocular Health

The question, “Can you take semaglutide if you have glaucoma?” is complex and does not have a simple yes or no answer. The relationship between semaglutide and eye health, particularly glaucoma, is an active area of research, presenting a nuanced picture with both emerging protective potentials and important considerations regarding possible side effects. Understanding these facets is key to making informed decisions with your healthcare team.

The Positive: Emerging Neuroprotective Potential for Glaucoma

Intriguingly, recent research suggests that GLP-1 receptor agonists, including semaglutide, may offer neuroprotective benefits that could be relevant in the context of neurodegenerative diseases like glaucoma. Our innovative approach at TrimRx means we stay abreast of such developments, always focusing on how scientific advancements can contribute to overall well-being.

GLP-1 Receptor Agonists and Neuroprotection

Beyond their well-established roles in metabolic regulation, GLP-1 receptor agonists have been shown to cross the blood-brain barrier and exhibit neuroprotective properties in various animal models of neurodegenerative conditions. These include diseases affecting the brain, such as Alzheimer’s and Parkinson’s, as well as ocular conditions like diabetic retinopathy. This broader neuroprotective effect stems from several mechanisms, including:

• Anti-inflammatory effects: Reducing inflammation in neural tissues.
• Antioxidant properties: Protecting cells from oxidative stress.
• Improved cellular energy metabolism: Supporting the health and function of neurons.
• Enhanced cellular survival pathways: Promoting the longevity of nerve cells.

These findings suggest that GLP-1 signaling may play a role in safeguarding neuronal health, a concept that is particularly relevant for conditions like glaucoma, where progressive loss of retinal ganglion cells is the hallmark.

Specific Studies and Clinical Trials on Glaucoma

A growing body of evidence, including recent registry-based case-control studies, has begun to associate the use of GLP-1 receptor agonists with a reduced risk of glaucoma. For instance, research published in Ophthalmology indicates that patients without diabetes who use GLP-1RAs for obesity treatment may experience a significantly lower risk of primary open-angle glaucoma (POAG) and ocular hypertension compared to those using other weight loss therapies. One study observed a 50.4% lower risk of POAG at 3 years and 58.5% less at 5 years for the GLP-1RA group, along with even greater reductions in ocular hypertension risk. These findings are compelling, suggesting a potential direct or indirect protective effect. The researchers postulate that weight management achieved through GLP-1RAs, combined with potential reductions in eye inflammation, could contribute to this observed benefit. This area of research is still evolving, but the initial results are promising.

Furthermore, a significant clinical trial (NCT06792422) is currently underway, specifically investigating whether oral semaglutide can treat open-angle glaucoma. This study, recruiting participants aged 45 and older, aims to determine if oral semaglutide can safely improve inner retinal function in patients with open-angle glaucoma, as measured by the photopic negative response of the electroretinogram. Participants will take either semaglutide or a placebo daily for six months, with regular clinic visits to monitor eye health. The study, expected to conclude in 2028, specifically excludes individuals with diabetes or renal impairment, focusing solely on the direct effect of semaglutide on glaucoma progression. The inclusion of quality of life questionnaires also highlights the comprehensive assessment of potential benefits.

These studies strongly support further research into the use of agents that increase GLP-1 receptor signaling as anti-glaucomatous treatment strategies, potentially offering a neuroprotective route beyond traditional IOP-lowering approaches.

The Cautious: Potential Ocular Side Effects and Considerations

While the neuroprotective potential of semaglutide for glaucoma is an exciting area of study, it’s equally important to acknowledge and understand potential ocular side effects that have been reported with GLP-1 receptor agonists. Our commitment to transparent service means we want you to be fully informed, enabling a thorough discussion with your primary care physician and ophthalmologist.

Temporary Blurred Vision

One of the more common, albeit usually temporary, side effects associated with semaglutide and similar medications is blurred vision. This phenomenon is often linked to the rapid changes in blood sugar levels that can occur when starting or adjusting diabetes medications, including GLP-1 receptor agonists. Fluctuations in blood sugar can affect the shape of the eye’s lens, leading to transient blurring.

This side effect is generally more noticeable in older patients, as the eye’s lens becomes less flexible with age, making it take longer for vision to stabilize as the body adapts to new blood sugar levels. The good news is that this blurred vision typically subsides within three to four months as blood sugar levels stabilize. If you experience blurry vision, it’s important to mention it to your healthcare provider, but in most cases, it resolves on its own.

Worsening of Diabetic Retinopathy

For individuals living with diabetes, there is a specific concern regarding diabetic retinopathy, a leading cause of vision loss where high blood sugar levels damage the tiny blood vessels in the retina. Some studies have suggested an association between rapid blood sugar control, such as that achieved with semaglutide, and a temporary worsening of diabetic retinopathy, particularly in its advanced stages. This doesn’t mean the medication causes retinopathy, but rather that very quick shifts in glucose levels might sometimes exacerbate existing retinopathy.

It’s crucial for individuals with diabetes, especially those with pre-existing diabetic retinopathy, to inform their ophthalmologist if they are considering or taking semaglutide. Regular eye examinations are essential to monitor for any changes and to manage diabetic eye disease proactively. For the majority of people, this is a manageable issue, but vigilance and close collaboration with your eye care specialist are paramount. The FOCUS study is currently evaluating the long-term effects of semaglutide on diabetic retinopathy in people with type 2 diabetes, with results expected in 2027.

Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

A more recent and significant concern regarding semaglutide and eye health involves a rare but serious condition called non-arteritic anterior ischemic optic neuropathy (NAION). NAION is the most common cause of sudden optic nerve blindness in adults, characterized by reduced blood flow to the optic nerve head, leading to permanent vision loss in one eye. There are currently no effective treatments for NAION.

A study published in JAMA Ophthalmology in July 2024, led by investigators from Mass Eye and Ear, was the first to report an association between semaglutide use (Ozempic and Wegovy) and a higher risk of developing NAION. The study found that patients with diabetes who were prescribed semaglutide were more than four times more likely to be diagnosed with NAION, and those who were overweight or had obesity were more than seven times more likely. While the study’s findings are significant, it’s important to place them in context:

• Rarity of NAION: NAION is a relatively uncommon condition, affecting up to 10 out of 100,000 people in the general population. While the relative risk was higher, the absolute risk remains low due to the rarity of the condition itself.
• Association, Not Causality: The study found an association between semaglutide use and NAION risk, but it does not definitively prove causation. More research is needed to understand the underlying mechanisms, if any, and to confirm this link in larger, more diverse populations.
• Existing Risk Factors: Individuals with diabetes are already at an increased risk for NAION, regardless of semaglutide use.
• Consultation is Key: Experts emphasize that patients should be aware of this information and discuss their individual risk profile with their care team. If patients are already taking semaglutide and have not experienced any symptoms, they should continue their medication as instructed and address any concerns with their physician.

This new information underscores the critical importance of open communication with your healthcare provider, especially if you have other known optic nerve problems like glaucoma or pre-existing significant visual loss from other causes. Your medical team can help weigh the potential benefits of semaglutide against these newly identified considerations, ensuring a decision tailored to your unique health profile.

Personalized Care: Your Journey with TrimRx

At TrimRx, we are deeply committed to providing personalized, medically supervised weight loss solutions that prioritize your safety and long-term health. We understand that navigating the complexities of health conditions, like glaucoma, alongside weight management goals requires a supportive and expert approach. Our platform is designed to be a user-friendly and supportive space where individuals receive comprehensive care tailored to their unique needs.

The Importance of Medical Supervision

Given the nuanced relationship between medications like semaglutide and conditions such as glaucoma, medical supervision is not just important—it’s essential. Weight loss medications are powerful tools that require careful consideration of an individual’s complete health profile, including existing medical conditions, other medications, and potential risks.

Our approach at TrimRx ensures that every individual embarking on a weight loss journey with prescription medication receives a thorough evaluation by qualified healthcare professionals. This involves:

• Doctor Consultations: Comprehensive virtual consultations where our medical team reviews your health history, discusses your weight loss goals, and assesses your eligibility for specific treatments. This is where you can openly discuss conditions like glaucoma and any concerns you may have about ocular health.
• Lab Work: Necessary lab tests are often part of the assessment to get a full picture of your health, monitor key indicators, and ensure the chosen treatment plan is safe and appropriate.
• Personalized Treatment Plans: Based on your assessment, a customized plan is developed that may include prescription weight loss medications, tailored to your specific needs and health status. We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach.

Our Comprehensive Service and Product Offerings

TrimRx provides a comprehensive service that encompasses every aspect of your weight loss journey, ensuring you have the support and resources needed for success. This includes:

• Medication: Access to clinically proven prescription medications such as Compounded Semaglutide, Oral Semaglutide, Ozempic®, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, and Wegovy®. These medications are provided through FDA-registered and inspected pharmacies, upholding the highest standards of safety and quality. It’s important to remember that while branded medications like Ozempic®, Wegovy®, Zepbound®, and Mounjaro® are FDA-approved, compounded medications are not, though they are prepared by FDA-registered and inspected pharmacies.
• Unlimited Support: Our dedicated care team is available to offer ongoing guidance, answer questions, and provide encouragement throughout your journey.
• Shipping: Convenient and transparent shipping of your medication directly from our partner pharmacies, with no hidden fees.

Our brand is empathetic, innovative, trustworthy, supportive, results-oriented, and personalized. We combine advanced medical science with modern technology to deliver compassionate care. To discover if one of our personalized prescription weight loss programs is right for you, we encourage you to take our free assessment quiz today.

Supporting Your Wellness Journey with TrimRx Supplements

Beyond prescription medications, TrimRx also offers quick-access supplements designed to support your overall wellness during your weight loss journey. These supplements do not require a quiz or a prescription, making them readily available to complement your healthy lifestyle.

GLP-1 Daily Support

Our GLP-1 Daily Support supplement is crafted to naturally enhance the body’s own GLP-1 hormone activity. This can contribute to better satiety, appetite regulation, and healthy blood sugar levels, all of which are beneficial for weight management and overall metabolic health. It’s an excellent option for those looking for natural support to optimize their body’s metabolic functions.

Weight Loss Boost

For individuals seeking additional support for their weight loss efforts, our Weight Loss Boost supplement is formulated with ingredients known to support metabolism and energy levels. This supplement can be a valuable addition to your daily routine, helping to energize your body and support your efforts towards achieving your weight loss goals.

These quick-access supplements are designed to provide foundational support, whether you are on a prescription weight loss program or simply looking to enhance your wellness journey with science-backed nutritional support.

Making an Informed Decision: Consulting Your Healthcare Provider

Ultimately, the decision of whether to take semaglutide if you have glaucoma, or any other pre-existing health condition, rests on a thorough discussion with your healthcare providers. This blog post serves as a comprehensive guide to the current understanding of the relationship between semaglutide and eye health, but it is not a substitute for professional medical advice.

The Importance of a Collaborative Approach

Your health is a complex tapestry, and decisions about new medications must consider every thread. This is particularly true when managing a condition like glaucoma, where vision loss is irreversible. A collaborative approach involving your primary care physician, your ophthalmologist, and the TrimRx medical team is paramount.

Here’s what to discuss:

• Full Medical History: Provide your doctors with a complete overview of your health, including all existing conditions, past surgeries, and any family history of eye diseases like glaucoma or NAION.
• Current Medications and Supplements: Disclose all prescription medications, over-the-counter drugs, and supplements you are currently taking. This helps identify any potential interactions.
• Glaucoma Status: Share details about your glaucoma diagnosis, including its type, stage, current treatment, and how well your intraocular pressure is controlled.
• Personal Risk Factors: Discuss any personal risk factors you have for NAION, diabetic retinopathy, or other ocular conditions.
• Benefits vs. Risks: Have an open conversation about the potential benefits of semaglutide for your metabolic health and weight loss goals, weighed against the potential ocular considerations, including the newly reported association with NAION and the potential for worsening diabetic retinopathy.

Your doctors can help assess your individual risk profile, explain the implications of semaglutide use in your specific case, and monitor your health closely throughout treatment. This might include recommendations for more frequent eye exams or specific tests.

Prioritizing Regular Eye Examinations

Regardless of whether you are considering or currently taking semaglutide, prioritizing regular comprehensive eye examinations is crucial, especially if you have glaucoma or diabetes. These exams allow your ophthalmologist to:

• Monitor Glaucoma Progression: Track changes in your optic nerve, visual field, and intraocular pressure.
• Detect Diabetic Retinopathy: Identify any signs of diabetic retinopathy or its progression.
• Screen for Other Eye Conditions: Check for other potential eye health issues, including signs of NAION or macular complications.

Early detection and management are key to preserving vision in conditions like glaucoma and diabetic retinopathy. Promptly report any new or worsening vision symptoms, such as blurred vision, peripheral vision loss, dark spots, or changes in color perception, to your eye doctor immediately.

At TrimRx, we are committed to providing you with the knowledge and tools to make empowered health choices. While we offer innovative solutions for weight loss, we also champion a holistic view of health that includes diligent management of all existing conditions. To explore how our personalized programs could fit into your broader health strategy, take our free assessment quiz and start a conversation with our medical team.

Conclusion

The decision to take semaglutide, especially when managing an existing condition like glaucoma, is a deeply personal one that requires careful consideration and expert guidance. As we’ve explored, the relationship between semaglutide and eye health is multifaceted, presenting both encouraging potential and important considerations. On one hand, emerging research suggests that GLP-1 receptor agonists, including semaglutide, may hold neuroprotective properties that could potentially benefit individuals with glaucoma, with ongoing clinical trials actively investigating this exciting possibility. On the other hand, it’s essential to be aware of potential side effects such as temporary blurred vision, the rare possibility of worsening diabetic retinopathy in some individuals, and the recently identified association with non-arteritic anterior ischemic optic neuropathy (NAION).

At TrimRx, our journey began with a shared vision to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions. We stand by our commitment to safe, effective weight loss and individualized care. Our platform is a user-friendly and supportive space where individuals receive personalized, medically supervised care, all designed to make sustainable weight loss attainable and tailored to the individual. We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach. This means ensuring you have all the necessary information to make the best choices for your overall health.

Navigating your health journey with a team of trusted professionals is paramount. If you have glaucoma or any other eye condition, it is vital to have an open and comprehensive discussion with your primary care physician and ophthalmologist about whether semaglutide is appropriate for you. They can help you weigh the benefits for metabolic health and weight management against any potential ocular risks, providing a personalized recommendation based on your unique medical history and risk factors. Regular eye exams remain an indispensable part of monitoring your eye health, especially when undergoing new treatments.

Should you be exploring medically supervised weight loss solutions, our compassionate team at TrimRx is here to support you every step of the way. We invite you to take our free assessment quiz to see if you qualify for one of our personalized prescription programs, including options like Compounded Semaglutide, Oral Semaglutide, Ozempic®, Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, and Wegovy®. All prescription medications are provided through FDA-registered and inspected pharmacies. Additionally, for immediate support, consider our quick-access supplements like GLP-1 Daily Support and Weight Loss Boost to enhance your wellness journey. Your path to a healthier life is unique, and we are here to provide the support, knowledge, and personalized care you deserve.

Frequently Asked Questions

Is semaglutide safe for everyone with glaucoma?

No, it is not a blanket recommendation. The safety of semaglutide for individuals with glaucoma is complex and depends on various factors, including the type and stage of glaucoma, overall eye health, presence of other conditions like diabetes or diabetic retinopathy, and individual risk factors. While some studies suggest potential neuroprotective benefits of GLP-1 agonists, others highlight potential ocular side effects like NAION. A thorough discussion with your ophthalmologist and primary care physician is crucial to assess your personal risk-benefit profile.

Can semaglutide worsen my glaucoma?

There is no direct evidence that semaglutide directly worsens glaucoma progression itself. However, rapid changes in blood sugar levels, which semaglutide can induce, might temporarily affect vision or, in rare cases, exacerbate existing diabetic retinopathy. More recently, an association between semaglutide use and a higher risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition affecting the optic nerve, has been reported. While NAION is distinct from glaucoma, it causes optic nerve damage and vision loss, which is a significant consideration. Your doctors will need to monitor you closely.

Are there any benefits of semaglutide for glaucoma patients?

Interestingly, some emerging research suggests that GLP-1 receptor agonists, including semaglutide, may have neuroprotective properties that could potentially benefit the optic nerve, which is affected in glaucoma. Studies have indicated a reduced risk of primary open-angle glaucoma and ocular hypertension in non-diabetic obese patients taking GLP-1RAs. There is also an ongoing clinical trial specifically investigating oral semaglutide as a potential treatment to improve inner retinal function in open-angle glaucoma. These are promising areas, but more definitive research is needed.

What should I do if I have glaucoma and am considering taking semaglutide?

If you have glaucoma and are considering semaglutide, the most important step is to consult comprehensively with both your primary care physician and your ophthalmologist. Provide them with your full medical history, including all medications and supplements you take, and details about your glaucoma diagnosis. Discuss the potential benefits of semaglutide for your metabolic health and weight loss goals against the identified ocular considerations and your personal risk profile. They can help you make an informed decision and ensure proper monitoring of your eye health throughout treatment. If you’re looking for personalized weight loss solutions, take our free assessment quiz to see if you qualify for a TrimRx program.